| Dr Khama D Ennis, MD, MPH | |
|
26 S Prospect St Ste 7, Amherst, MA 01002-2268 | |
| (413) 800-6968 | |
| Not Available |
| Full Name | Dr Khama D Ennis |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 26 S Prospect St Ste 7, Amherst, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669453973 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 223355 (Massachusetts) | Primary |
| Entity Name | Cd Practice Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295787919 PECOS PAC ID: 2567359839 Enrollment ID: O20040302000290 |
News Archive
The report by the Government Accountability Office noted that the federal government has missed several deadlines, and there is a risk it won't be ready to open the online marketplaces Oct. 1. But the report also noted some positive signs.
A new report by Sheffield Hallam University has revealed that, despite an abundance of government recommendations on end of life care in England, there is uncertainty as to whether they have led to improvements in patient care.
A new study by Ohio State University cancer researchers shows that boosting the level of a molecule called miR-29b in acute myeloid leukemia (AML) cells can reverse gene changes that trap the cells in an immature, fast growing state of development.
One of the most reliable indicators to predict that a person will develop type 2 diabetes is the presence of insulin resistance.
LIUS Molecular Design is pleased to announce that it has successfully created two antipsychotic drug candidates with third party confirmation of predicted biological activities via in vitro testing.
› Verified 1 days ago
| Entity Name | Vineyard Complementary Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053490896 PECOS PAC ID: 2860435005 Enrollment ID: O20170310000520 |
News Archive
The report by the Government Accountability Office noted that the federal government has missed several deadlines, and there is a risk it won't be ready to open the online marketplaces Oct. 1. But the report also noted some positive signs.
A new report by Sheffield Hallam University has revealed that, despite an abundance of government recommendations on end of life care in England, there is uncertainty as to whether they have led to improvements in patient care.
A new study by Ohio State University cancer researchers shows that boosting the level of a molecule called miR-29b in acute myeloid leukemia (AML) cells can reverse gene changes that trap the cells in an immature, fast growing state of development.
One of the most reliable indicators to predict that a person will develop type 2 diabetes is the presence of insulin resistance.
LIUS Molecular Design is pleased to announce that it has successfully created two antipsychotic drug candidates with third party confirmation of predicted biological activities via in vitro testing.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Khama D Ennis, MD, MPH 26 S Prospect St Ste 7, Amherst, MA 01002-2268 Ph: (413) 800-6968 | Dr Khama D Ennis, MD, MPH 26 S Prospect St Ste 7, Amherst, MA 01002-2268 Ph: (413) 800-6968 |
News Archive
The report by the Government Accountability Office noted that the federal government has missed several deadlines, and there is a risk it won't be ready to open the online marketplaces Oct. 1. But the report also noted some positive signs.
A new report by Sheffield Hallam University has revealed that, despite an abundance of government recommendations on end of life care in England, there is uncertainty as to whether they have led to improvements in patient care.
A new study by Ohio State University cancer researchers shows that boosting the level of a molecule called miR-29b in acute myeloid leukemia (AML) cells can reverse gene changes that trap the cells in an immature, fast growing state of development.
One of the most reliable indicators to predict that a person will develop type 2 diabetes is the presence of insulin resistance.
LIUS Molecular Design is pleased to announce that it has successfully created two antipsychotic drug candidates with third party confirmation of predicted biological activities via in vitro testing.
› Verified 1 days ago
Gregory W. Little, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000 Fax: 413-577-5440 | |
David H Nielsen, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 17 Stagecoach Rd, Amherst, MA 01002 Phone: 413-253-3842 |